Literature DB >> 12885297

SH2-containing inositol 5-phosphatases 1 and 2 in blood platelets: their interactions and roles in the control of phosphatidylinositol 3,4,5-trisphosphate levels.

Sylvie Giuriato1, Xavier Pesesse, Stéphane Bodin, Takehiko Sasaki, Cécile Viala, Evelyne Marion, Joseph Penninger, Stéphane Schurmans, Christophe Erneux, Bernard Payrastre.   

Abstract

Src homology domain 2-containing inositol 5-phosphatases 1 and 2 (SHIP1 and SHIP2) are capable of dephosphorylating the second messenger PtdIns(3,4,5) P3 (phosphatidylinositol 3,4,5-trisphosphate) and interacting with several signalling proteins. SHIP1 is essentially expressed in haematopoietic cells, whereas SHIP2, a closely related enzyme, is ubiquitous. In the present study, we show that SHIP1 and SHIP2 are expressed as functional PtdIns(3,4,5) P3 5-phosphatases in human blood platelets and are capable of interacting when these two lipid phosphatases are co-expressed, either naturally (platelets and A20 B lymphoma cells) or artificially (COS-7 cells). Using COS-7 cells transfected with deletion mutants of SHIP2, we demonstrate that the Src homology domain 2 of SHIP2 is the minimal and sufficient protein motif responsible for the interaction between the two phosphatases. These results prompted us to investigate the relative importance of SHIP1 and SHIP2 in the control of PtdIns(3,4,5) P3 levels in platelets using homozygous or heterozygous SHIP1- or SHIP2-deficient mice. Our results strongly suggest that SHIP1, rather than SHIP2, plays a major role in controlling PtdIns(3,4,5) P3 levels in response to thrombin or collagen activation of mouse blood platelets.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12885297      PMCID: PMC1223743          DOI: 10.1042/BJ20030581

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  47 in total

1.  The two SH2-domain-containing inositol 5-phosphatases SHIP1 and SHIP2 are coexpressed in human T lymphocytes.

Authors:  C Bruyns; X Pesesse; C Moreau; D Blero; C Erneux
Journal:  Biol Chem       Date:  1999 Jul-Aug       Impact factor: 3.915

2.  Distribution of the src-homology-2-domain-containing inositol 5-phosphatase SHIP-2 in both non-haemopoietic and haemopoietic cells and possible involvement of SHIP-2 in negative signalling of B-cells.

Authors:  E Muraille; X Pesesse; C Kuntz; C Erneux
Journal:  Biochem J       Date:  1999-09-15       Impact factor: 3.857

3.  The SH2 domain containing inositol 5-phosphatase SHIP2 associates to the immunoreceptor tyrosine-based inhibition motif of Fc gammaRIIB in B cells under negative signaling.

Authors:  E Muraille; P Bruhns; X Pesesse; M Daëron; C Erneux
Journal:  Immunol Lett       Date:  2000-04-03       Impact factor: 3.685

4.  The SH2-containing inositol-5'-phosphatase enhances LFA-1-mediated cell adhesion and defines two signaling pathways for LFA-1 activation.

Authors:  J A Rey-Ladino; M Huber; L Liu; J E Damen; G Krystal; F Takei
Journal:  J Immunol       Date:  1999-05-15       Impact factor: 5.422

5.  A rapid method of total lipid extraction and purification.

Authors:  E G BLIGH; W J DYER
Journal:  Can J Biochem Physiol       Date:  1959-08

6.  A key role of adenosine diphosphate in the irreversible platelet aggregation induced by the PAR1-activating peptide through the late activation of phosphoinositide 3-kinase.

Authors:  C Trumel; B Payrastre; M Plantavid; B Hechler; C Viala; P Presek; E A Martinson; J P Cazenave; H Chap; C Gachet
Journal:  Blood       Date:  1999-12-15       Impact factor: 22.113

Review 7.  The role of SHIP in growth factor induced signalling.

Authors:  M Huber; C D Helgason; J E Damen; M Scheid; V Duronio; L Liu; M D Ware; R K Humphries; G Krystal
Journal:  Prog Biophys Mol Biol       Date:  1999       Impact factor: 3.667

8.  pp60c-src associates with the SH2-containing inositol-5-phosphatase SHIP1 and is involved in its tyrosine phosphorylation downstream of alphaIIbbeta3 integrin in human platelets.

Authors:  S Giuriato; S Bodin; C Erneux; R Woscholski; M Plantavid; H Chap; B Payrastre
Journal:  Biochem J       Date:  2000-05-15       Impact factor: 3.857

9.  BCR/ABL directly inhibits expression of SHIP, an SH2-containing polyinositol-5-phosphatase involved in the regulation of hematopoiesis.

Authors:  M Sattler; S Verma; C H Byrne; G Shrikhande; T Winkler; P A Algate; L R Rohrschneider; J D Griffin
Journal:  Mol Cell Biol       Date:  1999-11       Impact factor: 4.272

10.  SHIP2 overexpression strongly reduces the proliferation rate of K562 erythroleukemia cell line.

Authors:  Sylvie Giuriato; Daniel Blero; Bernard Robaye; Catherine Bruyns; Bernard Payrastre; Christophe Erneux
Journal:  Biochem Biophys Res Commun       Date:  2002-08-09       Impact factor: 3.575

View more
  14 in total

Review 1.  Macrophage polarization: the link between inflammation and related diseases.

Authors:  Samina Bashir; Yadhu Sharma; Asif Elahi; Farah Khan
Journal:  Inflamm Res       Date:  2016-01       Impact factor: 4.575

2.  Akt signaling in platelets and thrombosis.

Authors:  Donna S Woulfe
Journal:  Expert Rev Hematol       Date:  2010-02       Impact factor: 2.929

Review 3.  The impact of phosphoinositide 5-phosphatases on phosphoinositides in cell function and human disease.

Authors:  Ana Raquel Ramos; Somadri Ghosh; Christophe Erneux
Journal:  J Lipid Res       Date:  2018-09-07       Impact factor: 5.922

4.  A dual role for the class III PI3K, Vps34, in platelet production and thrombus growth.

Authors:  Colin Valet; Marie Levade; Gaëtan Chicanne; Benoit Bilanges; Cendrine Cabou; Julien Viaud; Marie-Pierre Gratacap; Frédérique Gaits-Iacovoni; Bart Vanhaesebroeck; Bernard Payrastre; Sonia Severin
Journal:  Blood       Date:  2017-09-13       Impact factor: 22.113

5.  SHIP2 (SH2 domain-containing inositol phosphatase 2) SH2 domain negatively controls SHIP2 monoubiquitination in response to epidermal growth factor.

Authors:  Julie De Schutter; Aude Guillabert; Virginie Imbault; Chantal Degraef; Christophe Erneux; David Communi; Isabelle Pirson
Journal:  J Biol Chem       Date:  2009-10-30       Impact factor: 5.157

6.  Lyn, PKC-delta, SHIP-1 interactions regulate GPVI-mediated platelet-dense granule secretion.

Authors:  Ramya Chari; Soochong Kim; Swaminathan Murugappan; Archana Sanjay; James L Daniel; Satya P Kunapuli
Journal:  Blood       Date:  2009-07-08       Impact factor: 22.113

7.  Deficiency of Src homology 2 domain-containing inositol 5-phosphatase 1 affects platelet responses and thrombus growth.

Authors:  Sonia Séverin; Marie-Pierre Gratacap; Nadège Lenain; Laetitia Alvarez; Etienne Hollande; Josef M Penninger; Christian Gachet; Monique Plantavid; Bernard Payrastre
Journal:  J Clin Invest       Date:  2007-03-08       Impact factor: 14.808

8.  Evidence for SH2 domain-containing 5'-inositol phosphatase-2 (SHIP2) contributing to a lymphatic dysfunction.

Authors:  Germaine D Agollah; Manuel L Gonzalez-Garay; John C Rasmussen; I-Chih Tan; Melissa B Aldrich; Chinmay Darne; Caroline E Fife; Renie Guilliod; Erik A Maus; Philip D King; Eva M Sevick-Muraca
Journal:  PLoS One       Date:  2014-11-10       Impact factor: 3.240

Review 9.  Phosphoinositide phosphatases in a network of signalling reactions.

Authors:  Daniel Blero; Bernard Payrastre; Stéphane Schurmans; Christophe Erneux
Journal:  Pflugers Arch       Date:  2007-06-29       Impact factor: 4.458

10.  SH2-inositol phosphatase 1 negatively influences early megakaryocyte progenitors.

Authors:  Lia E Perez; Caroline Desponts; Nancy Parquet; William G Kerr
Journal:  PLoS One       Date:  2008-10-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.